Grifols Announces Completion Of Follow-Up For All 345 Patients In Phase 3 SPARTA Trial Of Prolastin-C In Alpha-1 Emphysema; Topline Data Expected By End Of 2026

Loading news article.

Grifols Announces Completion Of Follow-Up For All 345 Patients In Phase 3 SPARTA Trial Of Prolastin-C In Alpha-1 Emphysema; Topline Data Expected By End Of 2026 | WAPE

Grifols Announces Completion Of Follow-Up For All 345 Patients In Phase 3 SPARTA Trial Of Prolastin-C In Alpha-1 Emphysema; Topline Data Expected By End Of 2026

Article summary

Related companies

Comments —